IP Verse

Boehringer Ingelheim Vetmedica competitive analysis

Loading summary...

Latest oppositions filed by Boehringer Ingelheim Vetmedica

Explore patent oppositions filed by Boehringer Ingelheim Vetmedica against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3842456
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESJun 13, 2025
EP3653645
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESMay 20, 2025
EP4107159
5-(3-(Ethylsulfonyl)Pyridin-2-Yl)-Pyrazolo[1,5-A]Pyrimidine Derivatives And Related Compounds As Pesticide And Insecticide Agents For Crop ProtectionPI INDUSTRIESJan 16, 2025
EP3300743
Methods Of Vaccine AdministrationZOETIS SERVICESMar 13, 2024
EP3733672
Heterocyclic Compounds And Noxious Arthropod Control Agent Containing SameSUMITOMO CHEMICALDec 20, 2023
EP3471766
Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Infectious Bursal Disease Virus AntigensINTERVETSep 12, 2023
EP2833908
Mycoplasma Hyopneumoniae VaccineZOETISOct 3, 2022
EP2970916
Adapted Lepidopteran Insect Cells For The Production Of Recombinant ProteinsMERCK SHARP & DOHMEJan 14, 2022
EP2994162
Vaccine For Pcv2 And MycoplasmaPHARMGATE BIOLOGICSJan 7, 2022
EP3219729
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESJun 9, 2021

Latest patents of Boehringer Ingelheim Vetmedica opposed by its competitors

Explore Boehringer Ingelheim Vetmedica's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2488145
Apr 24, 2024Containers For Compositions Comprising Meloxicam1
EP3862003
Oct 25, 2023An Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Disorder In Feline Animals1
EP3485890
May 10, 2023Treatment Of Metabolic Disorders In Canine Animals1
EP3534939
Feb 22, 2023Vaccine Against Porcine Parvovirus And Porcine Reproductive And Respiratory Syndrome Virus And Methods Of Production Thereof1
EP3035958
Oct 26, 2022Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine2
EP2275132
Mar 3, 2021Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them3
EP3127551
Jul 29, 2020Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs3
EP3320919
May 27, 2020Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions2
EP3344289
Jan 29, 2020Pestivirus Vaccines For Congenital Tremors1
EP2460820
Jun 19, 2019Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions3

Latest publications and patents of Boehringer Ingelheim Vetmedica New

Explore the latest publications and patents granted to Boehringer Ingelheim Vetmedica, showcasing their recent innovations and technological advancements.

Last updated on: Oct 22, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Boehringer Ingelheim Vetmedica

EP2488145
Apr 24, 2024Containers For Compositions Comprising MeloxicamGranted And Under Opposition
EP3862003
Oct 25, 2023An Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Disorder In Feline AnimalsGranted And Under Opposition
EP3485890
May 10, 2023Treatment Of Metabolic Disorders In Canine AnimalsRevoked
EP3534939
Feb 22, 2023Vaccine Against Porcine Parvovirus And Porcine Reproductive And Respiratory Syndrome Virus And Methods Of Production ThereofOpposition Rejected
EP3035958
Oct 26, 2022Porcine Circovirus Type 2 (Pcv2) Subunit VaccineGranted And Under Opposition
EP2275132
Mar 3, 2021Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing ThemGranted And Under Opposition
EP3127551
Jul 29, 2020Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In PigsGranted And Under Opposition
EP3320919
May 27, 2020Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsGranted And Under Opposition
EP3344289
Jan 29, 2020Pestivirus Vaccines For Congenital TremorsRevoked
EP2460820
Jun 19, 2019Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsRevoked

Latest PTAB cases involving Boehringer Ingelheim Vetmedica

Discover the latest PTAB cases involving Boehringer Ingelheim Vetmedica, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 28, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Boehringer Ingelheim Vetmedica

IPR2019-00374Nov 30, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICAInstitution Denied
IPR2019-00381Nov 30, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICATerminated-Settled
IPR2018-01788Sep 24, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICAInstitution Denied
IPR2018-01789Sep 24, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICAInstitution Denied

Peer Comparison New

IP litigation analysis comparing Boehringer Ingelheim Vetmedica with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BOEHRINGER INGELHEIM VETMEDICA1829 - 4
CEVA SANTE ANIMALE213 - -
INTERVET113441
LABORATORIOS HIPRA7 - - -